Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
22 USD | -0,09% | -1,52% | +26,77% |
Omzet 2024 * | 26,31 mln. 32,79 mln. 30,73 mln. | Omzet 2025 * | 36,37 mln. 45,32 mln. 42,47 mln. | Marktkapitalisatie | 824 mln. 1,03 mld. 962 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -42 mln. -52,34 mln. -49,05 mln. | Nettowinst (verlies) 2025 * | -72 mln. -89,72 mln. -84,09 mln. | EV/omzet 2024 * | 27,8 x |
Nettoliquiditeiten 2024 * | 91,29 mln. 114 mln. 107 mln. | Nettoliquiditeiten 2025 * | 82,95 mln. 103 mln. 96,87 mln. | EV/omzet 2025 * | 20,4 x |
K/w-verhouding 2024 * |
-47,1
x | K/w-verhouding 2025 * |
-33,8
x | Werknemers | 109 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 0% |
Recentste transcriptie over Silence Therapeutics plc
1 dag | +2,13% | ||
1 week | -1,52% | ||
Lopende maand | +1,94% | ||
1 maand | -8,29% | ||
3 maanden | +15,71% | ||
6 maanden | +181,95% | ||
Lopend jaar | +26,77% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Craig Tooman
CEO | Chief Executive Officer | 58 | 06-01-21 |
Director of Finance/CFO | 52 | 01-04-21 | |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Romano
CTO | Chief Tech/Sci/R&D Officer | 64 | 29-07-19 |
David Lemus
BRD | Director/Board Member | 61 | 21-06-18 |
Iain Ross
CHM | Chairman | 71 | 02-07-04 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.03% | 2 M€ | -.--% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-04-24 | 22,02 | +2,13% | 124 605 |
17-04-24 | 21,56 | +1,46% | 121 826 |
16-04-24 | 21,25 | +2,86% | 141 243 |
15-04-24 | 20,66 | -6,81% | 77 611 |
12-04-24 | 22,17 | -0,85% | 104 414 |
uitgestelde koers Nasdaq, 18 april 2024 om 22:00 uur
Meer koersen